Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Pakistan Journal of Pharmaceutical Sciences. 2018; 31 (4 [Special]): 1713-1717
en Inglés | IMEMR | ID: emr-199274

RESUMEN

The treatment of influenza A [H1N1] is mainly antiviral treatment, symptomatic treatment or traditional Chinese medicine treatment. Previous studies showed that the extract of Bupleurum has the functions of anti-inflammatory, antiviral, regulating the immune system and so on, which can be used to treat influenza. In this paper, we analyze the drug effect of bupleurum compound medicine, at the same time, using oseltamivir as control group. The results showed that the Chinese medicine chima qingwen decoction had certain antiviral effects. No adverse reactions occurred during the treatment period, and the overall effective rate was 93.3%. It shows that combination therapy of Chinese and Western medicine is feasible for mild cases of influenza A [H1N1]. Therefore, the research and development of Chinese medicine preparations has positive research significance and sufficient market potential

2.
Chinese Journal of Clinical Pharmacology and Therapeutics ; (12)2004.
Artículo en Chino | WPRIM | ID: wpr-566323

RESUMEN

Hepatocellular carcinoma is one of the largest causes of cancer-related deaths worldwide for which there are very limited effective treatment options.The ubiquitin-proteasome pathway(UPP) has rapidly become acknowledged as both critical mechanism for cellular biological function and a latent target of regulation of cancer-related disease.This review focus on the role of ubiquitin-proteasome pathway in hepatocellular carcinoma and its correlation factors(HBV、P27、NF-?B,et al),in order to find novel therapeutic interventions against the genesis and development of hepatocellular carcinoma.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA